Sofinnova Investments’s Boston Scientific BSX Stock Holding History

Sofinnova Investments’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-569,427	Closed	-$55.6M	–	62
2025 Q3	$55.6M	Buy	569,427 +138,227	+32%	+$14.3M	3.04%	8
2025 Q2	$46.3M	Buy	+431,200	New	+$43.6M	2.83%	9
2025 Q1	–	Sell	-346,571	Closed	-$31M	–	72
2024 Q4	$31M	Buy	346,571 +210,752	+155%	+$18.6M	2.25%	15
2024 Q3	$11.4M	Sell	135,819 -35,261	-21%	-$2.78M	0.9%	26
2024 Q2	$13.2M	Sell	171,080 -182,771	-52%	-$13.4M	0.68%	37
2024 Q1	$24.2M	Buy	353,851 +222,851	+170%	+$14.3M	1.35%	26
2023 Q4	$7.57M	Buy	+131,000	New	+$6.99M	0.42%	37
2023 Q3	–	Sell	-608,861	Closed	-$32.9M	–	69
2023 Q2	$32.9M	Buy	+608,861	New	+$31.8M	2.16%	15

Other funds holding BSX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Sofinnova Investments's BSX Position: Q4 2025 in Review

Sofinnova Investments sold out of Boston Scientific (BSX) in Q4 2025, closing a stake of 569,427 shares — an estimated $55.6M sold.

Sofinnova Investments first reported a position in BSX in Q2 2023 and held it in 8 quarters. The position peaked at $55.6M in Q3 2025. 1,783 funds tracked by Wall St. Rank hold BSX as of Q4 2025.

Sofinnova Investments reported no remaining Boston Scientific position as of Q4 2025 after selling out during the quarter.
Sofinnova Investments sold 569,427 Boston Scientific shares in Q4 2025, an estimated $55.6M.
Sofinnova Investments first reported a position in Boston Scientific in Q2 2023 and held it in 8 quarters.
Sofinnova Investments's Boston Scientific position peaked at $55.6M in Q3 2025.
1,783 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2025.

Based on Sofinnova Investments's 13F filing for Q4 2025, filed 13 Feb 2026.